Glucometric parameter changes in patients with type 2 diabetes during ramadan fasting: A prospective comparative real-world study

被引:1
|
作者
Al Hayek, Ayman [1 ]
Al Zahrani, Wael M. [1 ]
Al Dawish, Mohamed Abdulaziz [1 ]
机构
[1] Prince Sultan Mil Med City, Diabet Treatment Ctr, Dept Endocrinol & Diabet, Riyadh, Saudi Arabia
来源
METABOLISM OPEN | 2024年 / 23卷
关键词
Type 2 diabetes mellitus; Ramadan fasting; Glucose monitoring; Self-care management; GLYCEMIC CONTROL; GLUCOSE LEVEL; MELLITUS; CARE; ASSOCIATION; PROFILE; IMPACT;
D O I
10.1016/j.metop.2024.100304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study assessed glucometric changes in Type 2 diabetes mellitus (T2DM) patients before, during, and after Ramadan fasting using an intermittently scanned continuous glucose monitoring system (isCGMS). Methods: This prospective comparative study included T2DM patients aged 30-70 years who were receiving nonintensive insulin in Riyadh, Saudi Arabia. In addition to the baseline characteristics, glycated hemoglobin (HbA1c) and ambulatory glucose profile (AGP)-derived metric data were collected at three specific points: pre-, during-, and post-Ramadan. Self-care activities during Ramadan were evaluated using the Diabetes SelfManagement Questionnaire (DSMQ). Results: Overall, a total of 93 T2DM patients were enrolled in the study. Their mean age +/- SD age was 47.9 +/- 7.5 years, and 51.6 % of them were males. Compared with pre- and post-Ramadan, there was a significant decrease in HbA1c (p < 0.001 for both periods), average glucose level (p = 0.001 and p = 0.026, respectively), glucose variability (p = 0.043 and p = 0.005, respectively), and % time above the range of 181-250 mg/dL (p < 0.001 for both periods), as well as a significant increase in % time in target (70-180 mg/dL) during Ramadan (p < 0.001 for both periods). However, the % time below 54 mg/dL was slightly greater during Ramadan than both pre- and post-Ramadan (p <0.001 and p = 0.002, respectively). Furthermore, 32.3 % reported inadequate selfcare behaviors during Ramadan. Conclusions: Ramadan fasting could improve glucose levels in T2DM patients who were not on intensive insulin, with a relatively low incidence of hypoglycemia.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study)
    Pathan, Md Faruque
    Akter, Nazma
    Mustari, Marufa
    Saifuddin, M.
    Sharifuzzaman, Mirza
    Rahman, Mohammad Motiur
    Ripon, Mohammed
    Mohiuddin, S. M.
    Kamrul-Hasan, A. B. M.
    Hannan, Mohammad Abdul
    Alam, Muhammad Shah
    Mahjabeen, Samira
    Afsana, Faria
    Bakar, Muhammed Abu
    Haq, Tahniyah
    Ahammed, Afsar
    Talukder, Samir Kumar
    Sarkar, Sourav
    Selim, Shahjada
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [2] Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh
    Pathan, Md Faruque
    Akter, Nazma
    Selim, Shahjada
    Saifuddin, M.
    Qureshi, Nazmul Kabir
    Kamrul-Hasan, A. B. M.
    Hannan, Mohammad Abdul
    Ahmed, Md Ashraf Uddin
    Mustari, Marufa
    Chakraborty, Ashish Kumar
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2022, 15 : 4011 - 4021
  • [3] Ramadan fasting and glycemic control in patients with type 2 diabetes: A real-world data analysis
    Salih, A. Swan-Abu
    Chodick, G.
    Klein, P.
    Eilat-Adar, S.
    PRIMARY CARE DIABETES, 2025, 19 (02) : 184 - 189
  • [4] Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN
    Hassanein, Mohamed
    Al Sifri, Saud
    Shaikh, Shehla
    Raza, Syed Abbas
    Akram, Javed
    Rudijanto, Achmad
    Shaltout, Inass
    Fariduddin, Md.
    Mohamed, Wan Mohd Izani Bin Wan
    Al Awadi, Fatheya
    Durocher, Alexandra
    Cortese, Viviana
    Alessa, Thamer
    DIABETES THERAPY, 2021, 12 (06) : 1703 - 1719
  • [5] A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN
    Hassanein, Mohamed
    Al Sifri, Saud
    Shaikh, Shehla
    Raza, Syed Abbas
    Akram, Javed
    Pranoto, Agung
    Rudijanto, Achmad
    Shaltout, Inass
    Fariduddin, Md
    Mohamed, Wan Mohd Izani Wan
    Al Awadi, Fatheya
    Alessa, Thamer
    Gad, Ahmad
    Rosandi, Rulli
    Obyedallah, Ahmed
    Kamal, Seif
    Zaky, Albert Anwar
    Adi, Soebagio
    Aly, Amr
    Wibisono, Sony
    Shaaban, Ashraf
    Atty, Talaat Abd El
    Shehata, Ashraf
    Modi, K. D.
    El Deen, Bahaa Sharaf
    Kundan, Kunal
    Santosa, Benny
    Sayem, M. A.
    Pramono, Bowo
    Iftekhar, Mahboob
    Santoso, Budi
    Bin Habib, Maruf
    Eltoraby, Ehab
    Moazam
    Fathallah, Essam
    Khan, Morshed Ahmed
    Eliana, Fatimah
    Akter, Nazma
    Suharnadi, Franciscus Xaverius
    Sultana, Nusrat
    Shaker, George
    Selim, Shahjada
    Abdelrahman, Ghada
    Khan, Shahjamal
    Zufrie, Hendra
    Kolke, Sharat S.
    Sanusi, Himawan
    Dhand, Sunil
    Khsanti, Ida Ayu
    Bhattacharyya, Supratik
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163
  • [6] Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN
    Mohamed Hassanein
    Saud Al Sifri
    Shehla Shaikh
    Syed Abbas Raza
    Javed Akram
    Achmad Rudijanto
    Inass Shaltout
    Md. Fariduddin
    Wan Mohd Izani Bin Wan Mohamed
    Fatheya Al Awadi
    Alexandra Durocher
    Viviana Cortese
    Thamer Alessa
    Diabetes Therapy, 2021, 12 : 1703 - 1719
  • [7] Regional subanalyses of a real-world study in patients with type 2 diabetes treated with gliclazidemodified-release during fasting: DIA-RAMADAN
    Hassanein, M.
    Durocher, A.
    Cortese, V.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S300 - S301
  • [8] Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes Patients During Ramadan Fasting
    Soelistijo, Soebagijo Adi
    Aman, Andi Makbul
    Zufry, Hendra
    Pranoto, Agung
    Rudijanto, Achmad
    Hassanien, Mohamed
    ACTA MEDICA INDONESIANA, 2022, 54 (01) : 3 - 9
  • [9] A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting
    Al-Sofiani, Mohammed E.
    Alharthi, Sahar
    Albunyan, Sarah
    Alzaman, Naweed
    Klonoff, David C.
    Alguwaihes, Abdullah
    DIABETES CARE, 2024, 47 (04) : 683 - 691
  • [10] Impact of fasting during Ramadan in patients with type 2 diabetes mellitus
    Haydardedeoglu, Filiz Eksi
    Bagir, Gulay Simsek
    Ozsahin, Akatli Kursat
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (03): : 758 - 763